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Abstract
It is generally accepted that neuroendocrine cells regulate dense core vesicle (DCV) biogenesis and cargo packaging in
response to secretory demands, although the molecular mechanisms of this process are poorly understood. One factor that
has previously been implicated in DCV regulation is IA-2, a catalytically inactive protein phosphatase present in DCV
membranes. Our ability to directly visualize a functional, GFP-tagged version of an IA-2 homolog in live Caenorhabditis
elegans animals has allowed us to capitalize on the genetics of the system to screen for mutations that disrupt DCV
regulation. We found that loss of activity in the transcription factor PAG-3/Gfi-1, which functions as a repressor in many
systems, results in a dramatic up-regulation of IDA-1/IA-2 and other DCV proteins. The up-regulation of DCV components
was accompanied by an increase in presynaptic DCV numbers and resulted in phenotypes consistent with increased
neuroendocrine secretion. Double mutant combinations revealed that these PAG-3 mutant phenotypes were dependent on
wild type IDA-1 function. Our results support a model in which IDA-1/IA-2 is a critical element in DCV regulation and reveal a
novel genetic link to PAG-3-mediated transcriptional regulation. To our knowledge, this is the first mutation identified that
results in increased neurosecretion, a phenotype that has clinical implications for DCV-mediated secretory disorders.
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Introduction
Dense core vesicles (DCVs) mediate the storage and secretion of
hormones (e.g. insulin) and neuropeptides (e.g. vasoactive
intestinal peptide, VIP) from a variety of neuroendocrine cells
(e.g. pancreatic b-cells). The biogenesis of DCVs and cargo is
coordinately regulated, allowing secretory cell types to adjust their
output in response to nutrient (e.g. glucose) and endocrine signals
(e.g. glucagon) (reviewed in [1,2]). The molecular and cellular
mechanisms by which neuroendocrine cells achieve this coordi-
nated secretory regulation are poorly understood.
Recent work suggests that the DCV-associated protein Islet
Antigen-2 (IA-2, a.k.a ICA512) and its paralog, IA-2b (a.k.a.
Phogrin), might hold clues to these regulated secretory processes.
IA-2 and IA-2b are members of a family of protein tyrosine
phosphatases (PTP) that lack catalytic activity [3–8]. Both IA-2
and IA-2b are transmembrane proteins localized to DCVs and are
present in most, if not all, neuroendocrine tissues [6,9]. Mouse
knockouts of either IA-2 or IA-2b result in impaired glucose-
induced insulin secretion and elevated responses to glucose
tolerance tests [10,11]. The IA-2 and IA-2b double knockout
mice have enhanced phenotypes, including glucose intolerance
[12] and infertility in female mice due to reduced luteinizing
hormone secretion [13]. Over expression of IA-2 in insulin-
expressing MIN6 cells markedly increases glucose- or K
+-induced
insulin secretion, the number of secretory vesicles, the levels of
vesicle-associated proteins (such as synaptotagmin and VAMP2),
and the insulin content suggesting that IA-2 might be involved in
the stabilization of DCVs [14]. Finally, recent work suggests that
IA-2 can be cleaved in pancreatic b-cells upon glucose stimulation.
This cleavage releases a cytoplasmic tail of IA-2 that modulates the
activity of STAT5, a transcription factor regulating the transcrip-
tion of the insulin gene and other DCV components [15].
Together, these results implicate IA-2 and IA-2b as key players in
DCV and associated cargo abundance in pancreatic b-cells.
To further explore the role of IA-2/IA-2b in neuroendocrine
secretion, we have studied its functions in the model organism C.
elegans. C. elegans is a genetically tractable system with a simple
nervous system (302 neurons) that has made major contributions
to our understanding of synaptic vesicle (SV) [16,17] and DCV
trafficking and neuroendocrine secretion [18–21]. It has previously
been shown that the gene ida-1 encodes the single C. elegans factor
related to both mammalian IA-2 and IA-2b, and that IDA-1 is an
evolutionarily conserved neuroendocrine protein that is involved
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pathway [7,18,22]. Our DCV-specific IDA-1::GFP integrated
transgenic strain (KM246) has provided a unique marker for
studying DCV function using internal reflection fluorescence
microscopy and direct electrophysiological assays [21].
We report here on the characterization of a mutant isolated in a
genetic screen for abnormal patterns of IDA-1::GFP reporter gene
expression. The identified allele, gv560, results in markedly
increased levels of gene expression for multiple DCV components,
increased DCV numbers, and exhibits several behavioral pheno-
types linked to increased neuronal secretion. This mutation maps
to the gene pag-3/Gfi-1, which encodes a zinc-finger transcription
factor that functions as a repressor in many biological systems
(reviewed in [23]). We further show that the effects of pag-3
mutations on DCV biosynthesis are IDA-1-dependent, suggesting
that PAG-3-mediated repression is part of a regulatory mechanism
governing DCV numbers and cargo release.
Results
A Mutation in pag-3 Results in the Up-Regulation of IDA-
1::GFP
In order to investigate the molecular mechanisms regulating
DCV biosynthesis and turnover in vivo, we screened a mutagenized
population of C. elegans animals for altered patterns of IDA-1::GFP
(Figure 1A–E). The wild type IDA-1::GFP reporter strain we used
(KM246) harbors a full length translational fusion of IDA-1 to
GFP driven by a portion of its own promoter (Figure 1A) that
results in strong gfp expression in a subset of larval and adult
neurons; the endogenous distribution of IDA-1 is more widespread
than this particular reporter, and is perhaps ubiquitous within all
neurons and neurosecretory cells of the animal [18,24]. Specifi-
cally, we observed GFP in the following neurons in strain KM246
at the frequencies indicated parenthetically: ALA (a single neuron
of unknown function that extends a processes the length of the
body (100%)), VCs (hermaphrodite specific Ventral Cord motor
neurons involved in egg laying (100% VC4&VC5; 31% VC6;
26% for VC1-3), the HSNs (Hermaphrodite Specific Neurons
regulating egg laying (29%)), and PHCs (tail neurons, possibly
mechanosensory (18%)) (Figure 1B, C, E) [18]. A screen of 4,400
haploid genomes revealed three mutations that significantly
altered this reporter gene expression pattern; two had additional
developmental defects and were not maintained. The remaining
mutant allele, gv560, was homozygous viable and was fully
penetrant for multiple phenotypes, including significantly up-
regulated levels of IDA-1::GFP levels in a subset of neurons where
it is normally observed (Figure 1B–E). Some gv560 mutant neurons
consistently displayed increased levels of GFP (eg. VC4, VC5, and
ALA) whereas other neurons (eg. VC1,3, VC6, HSNs, and
PHCs) had a more variable pattern. These differences roughly
correlated with the degree of mosaic expression normally observed
for this integrated transgene in a wild type background, suggesting
these differences might simply reflect the functional efficiency of
the promoter element used in this particular reporter. In addition,
the gv560 allele resulted in extra presumptive neurons along the
posterior ventral midline (Figure 1D) and an uncoordinated (Unc)
phenotype, particularly when moving in the reverse direction. All
gv560 phenotypes were recessive.
The location and appearance of the extra neurons in gv560
animals suggested they might be surviving P cell lineage
descendants that normally are eliminated during larval develop-
ment by cell death [25]. A reporter gene driven by the lin-11
promoter (Plin-11::GFP) has previously been used to identify these
neurons in cell death mutants [26]. We crossed gv560 mutant
animals into a strain harboring Plin-11::GFP. While the Plin-11::GFP
is only present in VC1,VC6 neurons in wild type animals
(Figure 1F), we found that this reporter was also active in many of
the extra gv560 mutant cells (Figure 1G)[26]. This result strongly
suggested that most, if not all, extra neurons observed in
homozygous gv560 animals were VC-like neurons derived from
Pn.aap-like cell lineages that had failed to undergo normal
programmed cell deaths. The failure of programmed cell deaths in
ced-3 mutants also results in extra VC-like neurons [27].
Therefore, we crossed ced-3(n717) mutants with our IDA-1
reporter and assayed GFP levels. IDA-1::GFP was not increased
in the VC or VC-like neurons of ced-3 mutants when compared to
wild type animals (Figure 1H). Quantitative analysis of IDA-
1::GFP intensity in VC4 and VC5 neurons showed that the GFP
signal in gv560 is ,3.4-fold and ,5.6-fold of wild type respectively,
while the GFP signal in ced-3 mutant is similar to wild type
(Figure 1I).
Using genetic and single nucleotide polymorphism (SNP)
markers, we mapped the gv560 mutant to the right end of the X
chromosome (Figure 2A) (see Materials and Methods). There are
three known mutations in this region that result in an Unc
phenotype; unc-3, pag-3, and unc-7. One of these, pag-3, has
previously been shown to result in extra VC-like neurons due to
cell lineage alterations [26]. We found that gv560 failed to
complement two different pag-3 alleles (Figure 2B). Moreover, a
6.5 kb genomic fragment from the pag-3 genomic locus rescued
the gv560 mutant phenotypes (Figure 2C, D), indicating that gv560
is a mutant allele of pag-3.
The pag-3 gene encodes a zinc-finger (Zn-finger) transcription
factor that was originally identified in C. elegans due to altered gene
expression patterns in specific neurons (pattern of gene expression
abnormal, pag-3) [28]. More recently, pag-3 mutations have been
shown to affect cell fate decisions within certain lineages resulting
in the generation of additional posterior neurons [26]. Sequence
analysis of the pag-3 gene in the C. elegans gv560 mutant animals
revealed a C to T transition in exon 7 resulting in a S223F amino
acid change within the fourth Zn-finger coding region (Figure 2E).
Multiple sequences alignment showed that S227 in PAG-3 is
Author Summary
Within secretory cells, hormones are packaged into
vesicles (called DCVs) that are released upon stimulation.
The number of DCVs is regulated to meet the secretory
demands of the cell by a mechanism that is poorly
understood, although a protein in the membrane of DCVs,
called IA-2, is thought to play a role. A genetic screen in
the nematode C. elegans is used, here, to find mutations
that mis-regulate the corresponding worm protein called
IDA-1. Capitalizing on the simple neuroanatomy of the
nematode and its transparency, we visualize IDA-1 protein
levels directly in the animal using a fluorescent tag. We
find that mutations in the transcription factor PAG-3/Gfi-1
result in elevated levels of IDA-1 protein, increased
numbers of presynaptic DCVs, and behaviors consistent
with increased neurosecretion. Our results demonstrate
that IDA-1/IA-2 protein levels correlate with the biogene-
sis, utilization, or stability of DCVs. We propose that PAG-3
normally down regulates the production of IDA-1, thus
serving as part of the mechanism underlying DCV
regulation. This is the first reported mutation that
increases DCV numbers and secretion, offering insight
into DCV homeostasis and a potential therapeutic target
for diseases that would benefit from a boost in neuroen-
docrine secretion.
PAG-3 Regulates DCV Numbers through IDA-1
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shown). Examination of two previously identified pag-3 alleles (is20
and n3098) (Figure 2E), demonstrated that each had the same
phenotype as gv560 with respect to IDA-1::GFP levels, either alone
or in trans-heterozygous combination with gv650 (Figure 2B).
Because pag-3(ls20) (Figure 2E) has previously been shown to
behave genetically as a null allele [28], we conclude that gv560 is
also genetically null; we can not eliminate the possibility that it
retains some molecular function.
To determine if PAG-3 activity acted cell autonomously, we
sought to rescue the GFP over expression phenotype in a subset of
neurons expressing IDA-1::GFP in the pag-3(gv560) mutants. The
cat-1 gene encodes a synaptic vesicular monoamine transporter
[29] that has been reported to be expressed in several neurons
(Shawn Lockery, personal communication; http://chinook.uore-
gon.edu/promoters.html), including VC4, VC5 and the HSNs
where we see IDA-1::GFP phenotypes in the pag-3(gv560) mutant.
We confirmed this expression pattern using a ,3 kb region
upstream of the cat-1 coding region to drive GFP (data not shown);
this reporter was not expressed in ALA. The Pcat-1 promoter was
placed upstream of a wild type, full-length cDNA encoding PAG-3
and used to make stable, extrachromosomal transgenic strains in
the Pida-1::IDA-1::GFP; pag-3(gv560) mutant background. Interest-
ingly, we found that this transgene was often toxic, resulting in
several strains in which most transgenic animals arrested at the L1
stage of development and subsequently died. However, we were
also able to generate multiple, independent stable strains in which
transgenic animals grew normally, presumably reflecting expres-
sion of the transgene at a sub-toxic dose. We scored GFP levels in
these healthy strains, focusing on the VC4/5 versus ALA over
expression phenotypes because these cells always express IDA-
1::GFP. A visual screen revealed that 28% (n=100) of Pida-1IDA-
1::GFP; pag-3(gv560) mutants harboring the Pcat-1::PAG-3 trans-
gene had a reduction in VC4/5 GFP to near wild type levels
whereas GFP over expression in ALA remained unaffected
(Figure 2F, G). We did not expect full rescue as the extrachro-
mosomal rescuing transgene is mitotically unstable. A quantifica-
tion of GFP intensity in VC4 and VC5 for 15 selected animals of
each strain similarly showed a reduction (31%) in average intensity
in the rescued strain (Figure 2H). These results demonstrated that
wild type PAG-3 activity in VC4 and VC5 was likely acting cell
autonomously, with no change in the GFP over expression
phenotypes seen in neurons that did not express the Pcat-1::PAG-3
transgene.
To quantify the increased IDA-1::GFP levels in pag-3(gv560)
mutants, equal amounts of protein extract from gv560 animals
were compared to the parental reporter strain on Western blots
probed with anti-GFP and anti-IDA-1 antibodies. We found that
GFP levels in the gv560 mutant were approximately five times
higher than that in the parental controls when internally
compared to a tubulin protein control (Figure 3A). Interestingly,
the IDA-1 peptide containing protein levels in gv560 mutant,
Figure 1. Up-regulation of the IDA-1::GFP translational report-
er gene in normal and ectopic neurons in gv560 mutant
animals. (A) Schematic diagram of the integrated IDA-1::GFP
translational fusion reporter transgene in strain KM246 that was used
for genetic screens. SP, signal peptide; TM, transmembrane domain;
PTP, protein-tyrosine phosphatase-like domain. (B) Schematic diagram
of a C. elegans hermaphrodite showing the positions of relevant cell
bodies from the left lateral view with anterior to the left and dorsal to
the top. (C) Ventral view of IDA-1::GFP transgene expression in VC4,
VC5, VC6, PHC, and HSN neurons in wild type animals. (D) IDA-1::GFP
levels in gv560 mutant animals is markedly increased in VC4 and VC5
neurons and also is observed in four additional neurons (P9–P12
descendants) in the posterior region. (E) IDA-1::GFP in the cell body of
the ALA neuron in the head of a wild type (left panel) and gv560 mutant
(right panel) animal; images were collected with identical exposure
times. (F) Plin-11GFP reporter expression in VC1-6 cells in a wild type
animal. (G) Plin-11GFP reporter expression confirmed that the additional
posterior neurons observed in gv560 mutants are derived from P9–P12.
(H) IDA-1::GFP expression is observed in extra neurons derived from P9–
P12 in ced-3 mutant animals, but, it is not upregulated in VC or HSN
neurons (only HSN(R) is visible in this focal plane). (I) Average intensities
of IDA-1::GFP for five VC4 (left) or VC5 (right) neurons in each strain
were quantitated and compared between wild type controls and gv560
or ced-3(n717) mutants. **, P,0.01. All images are of adult animals
oriented with anterior to the left and (where possible) dorsal towards
the top. Scale bars indicate 40 mm.
doi:10.1371/journal.pgen.1000447.g001
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transgene, were nearly eight-fold higher than in controls. This
demonstrated that the changes in the reporter accurately reflected
alterations in endogenous IDA-1 protein levels and not merely
changes in the reporter gene expression.
pag-3 Mutations Result in the Up-Regulation of Multiple
DCV Components
To probe whether the effect of pag-3(gv560) was limited to IDA-1
protein or more generally applicable, we assayed five additional
neurosecretory components for which specific C. elegans antibodies
were available: (1) synaptotagmin (SNT-1), an integral membrane
proteinofsynapticvesicles(SVs)[30] thathasalsobeenimplicated in
DCV cargo release [31]; (2) synaptobrevin (SNB-1), an integral
membrane protein of SVs implicated in neurotransmitter release
[32] and for which mammalian data demonstrates its presence in
DCVs [33]. (3) RAB-3, a member of the Ras GTPase superfamily
that regulates the axonal distribution of SVs and DCVs and,
consequently, neurosecretion [22,34]; (4) UNC-31, a calcium-
activated protein for secretion (CAPS) homolog required for
DCV docking and cargo release (Livingstone, 1991, Ph.D. Thesis)
[21,35,36]; and (5) serotonin, a DCV cargo component present in
HSN neurons and several neurons in the head region [37]. We
found that the levels of SNT-1 and serotonin are substantially
Figure 2. The gv560 mutation is an allele of the gene pag-3, which encodes a zinc-finger transcription factor. (A) The genetic interval in
which gv560 was mapped genetically is shown with a 6.5-kb stretch of genomic DNA from the region shown below. The 11 exons of pag-3 (boxes)
were sequenced to identify the gv560 allele as a C to T mutation resulting in a change in an evolutionarily conserved amino acid (S223F) in exon 7 as
indicated by an arrow. (B) Trans heterozygous gv560/pag-3(ls20) animals showed the same phenotypes (IDA-1::GFP up regulation and extra neurons)
as either the gv560 or pag-3(ls20) homozygous single mutants (see Figure 1D). (C) pag-3(gv560) phenotypes are rescued by a 6.5-kb PCR product that
contains the putative promoter and all exons and introns of the wild type pag-3 gene. In both panels B and C, the mid-section of an adult animal is
shown with anterior to the left and dorsal at top, each imaged with identical exposure times. Scale bar represents 40 mm. (D) The percent of P9–P12
derived cells expressing the IDA-1::GFP transgene was compared in N2, gv560, and the rescued strain by counting 100 worms in each group,
demonstrating nearly full rescue by the wild type pag-3 transgene (**, P,0.01). (E) The gv560 allele results in a S223F mutation in the fourth zinc-
finger region. Several previously identified alleles of pag-3 are also indicated. (F–H) Cell autonomous rescue of the GFP up regulation phenotype with
a wild type encoding PAG-3 transgene. Representative ventral view images of Pida-1IDA-1::GFP levels in VC4 and VC5 (anterior to the left) in pag-
3(gv560) animals (F) and animals harboring a potentially rescuing transgene (G) using identical exposure conditions. Partial rescue was achieved by
expressing the full-length pag-3 cDNA under the cat-1 promoter (23 kb) from an extrachromosomal transgene. The Pcat-1 and Pida-1 promoters used
in these experiments have overlapping activity in VC4, VC5, and the HSNs, the only sites for which partial rescue was observed, demonstrating cell
autonomy for PAG-3 activity. (H) Quantitative analysis of GFP levels in VC4 and VC5 neuron cell bodies from images of 15 animals for each strain using
NIH ImageJ software. On average, animals harboring an extrachromosomal rescuing pag-3 transgene had a ,31% (P,0.01) reduction in the levels of
IDA-1::GFP in VC4 and VC5 when compared to non-rescued mutants; ALA neuron GFP intensity was not altered in the rescued animals (not shown).
Scale bar represents 40 mm.
doi:10.1371/journal.pgen.1000447.g002
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more moderately increased. In contrast, the level of proteins lacking
vesicle transmembrane motifs (e.g. RAB-3 and UNC-31) and the
control (a-tubulin) did not change in the gv560 mutant (Figure 3A).
It was possible that the increases in endogenous IDA-1, SNT-1,
and serotonin observed in pag-3(gv560) mutants were due to the extra
VC-like (and perhaps other undetected) neurons in these mutants. To
address this, we checked protein levels in the mutant ced-3 that also
results in extra VC-like neurons (and other cell types) due to a lack of
programmed celldeath [27]. There was no detectableincrease in any
assayed protein in ced-3(n717) m u t a n t sc o m p a r e dt ow i l dt y p e( d a t a
not shown), suggesting that observed protein increases in the pag-
3(gv560) mutant are due to up-regulation or increased stability of
these factors rather than the increased neuronal cell number.
The significantly increased IDA-1 protein levels in the pag-
3(gv560) mutant prompted us to explore DCV components more
thoroughly in ida-1 mutants alone. We assayed by Western blot the
levels of DCV-related proteins (IDA-1, SNT-1, SNB-1, RAB-3, and
UNC-31) in wild type animals and an ida-1(ok409) mutant using
tubulin as a control (Figure 4A). IDA-1 was undetectable, as
expected, in the predicted null allele of ida-1 [18]. Of the remaining
proteins tested, SNT-1 and RAB3 showed a slight reduction (,80%
of the N2 control, p,0.05) in ida-1(ok409) mutants (Figure 4A). We
alsoassayed serotoninlevelsin ida-1(ok409)mutantsasanexample of
a DCV cargo component and found a significant reduction (,50%
of the N2 controls, p,0.05) (Figure 4B). Interestingly, the increased
levels of SNT-1 and serotonin found in pag-3(gv560) animals are also
eliminated when IDA-1 activity is removed (Figure 4B–D). A
comparison between ida-1(ok409);pag-3(gv560) double mutant pro-
tein levels to ida-1(ok409) mutants alone demonstrates that ida-1 is
epistatic to pag-3 for the change in both SNT-1 and serotonin. We
concluded that loss of PAG-3 activity results inan up-regulation of at
least some vesicle-related components and that this up-regulation
also requires functional IDA-1.
pag-3(gv560) Mutants Have Altered Gene Expression that
is not ida-1-Dependent
Previously described roles of PAG-3/Gfi-1 and related proteins
in transcriptional repression (see review in [23]), coupled with the
increased levels of DCV component proteins in the gv560 mutant,
led us to examine DCV and SV component gene expression in
these mutant animals. We selected four genes whose products are
DCV-associated proteins, four genes that encode DCV cargo
proteins, four genes expected to function primarily in SV
pathways, and three non-vesicle related genes as controls
(Table 1). We used quantitative real-time polymerase chain
reaction (RT-PCR) assays to measure the expression of these 15
genes in young adult wild type and pag-3(gv560) mutant animals
relative to internal controls. We found that pag-3(gv560) mutants
showed significantly increased expression of three genes (Table 1),
including two that encode DCV-membrane associated proteins
(IDA-1 and SNT-1) and one encoding DCV cargo related protein
(INS-1 or insulin-like molecule 1). There were no changes in the
expression of SV genes and the three non-vesicle associated genes.
Interestingly, the DCV membrane-associated gene ida-1 showed
the greatest magnitude of change in pag-3(gv560) mutants (Table 1).
Because the up-regulation of at least some of the vesicle-related
proteins in pag-3(gv560) is dependent on the presence of wild type
IDA-1, we thought it possible that a feedback mechanism could
link vesicle biogenesis, utilization, or stability to gene expression.
Previous work has shown that a cleaved cytosolic tail of
mammalian IA-2/IDA-1 interacts and modulates the transcription
factor STAT-5 that, in turn, positively regulates insulin gene
expression [15]. This link between IA-2 and the transcription of a
DCV cargo-encoding gene in mammals prompted us to
investigate in C. elegans the role of ida-1 and sta-1 (encoding the
lone STAT-related factor) in DCV homeostasis. We first examined
the mRNA levels of all 15 genes listed in Table 1 by quantitative
real-time PCR in ida-1 mutants; we found no significant
differences compared to wild type levels. We also crossed ida-
1(ok409) into the pag-3(gv560) mutant background and repeated
the gene expression analysis. We found that the mRNA levels in
the pag-3(gv560);ida-1(ok409) double mutants remained the same as
in the pag-3(gv560) single mutant (except for ida-1 itself, data not
shown), demonstrating that transcriptional alterations caused by
loss of PAG-3 are not dependent on IDA-1 activity. Finally, we
crossed the presumptive null deletion allele sta-1(ok587) into the
IDA-1::GFP reporter strain, either alone or in combination with
Figure 3. Changes in IDA-1 and other dense core vesicle proteins in pag-3(gv650) mutants. (A) Transgenic IDA-1::GFP and endogenous
IDA-1 levels in gv560 mutants are elevated 5-fold and 8-fold, respectively, in pag-3(gv650) mutants compared to wild type animals as determined by
Western blot analysis. Quantitative analysis is shown to the left and blot signals to the right. SNT-1 and SNB-1 in the gv560 mutant are increased 2.9-
fold and 1.8-fold, respectively, whereas RAB3 and UNC-31 levels remained unchanged. Tubulin levels served as the protein loading control. **,
P,0.01, *, P,0.05. (B) The DCV cargo component serotonin is elevated 2.5-fold (P,0.01) in the HSN neurons of gv560 mutants versus controls as
shown by immunofluorescent staining of whole animals with an anti-serotonin antibody; exposure times and settings for both images was identical.
As indicated in the diagram at top, the adult animals imaged are oriented with anterior to the left and dorsal to the top. Scale bar represents 20 mm.
doi:10.1371/journal.pgen.1000447.g003
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The absence of STA-1 activity did not change any IDA-1 protein
phenotypes. Our data strongly suggest that the presence or
absence of IDA-1 alone has no effects on the transcriptional
regulation of the DCV and SV genes we examined in C. elegans nor
does the absence of STAT activity influence vesicle-associated
protein levels. Because the up-regulation of DCV components
observed in pag-3(gv560) is dependent on wild type IDA-1 activity,
whereas changes in gene expression are not, we conclude that the
role of IDA-1 in DCV regulation is post-transcriptional.
The Molecular Changes of pag-3(gv560) Correlate with
Altered Neurosecretion
To determine if the changes in gene expression and protein
levels observed in pag-3(gv560) mutants had behavioral conse-
quences, we tested two behaviors that reflect vesicle (DCV and SV)
cargo release: egg-laying and aldicarb resistance. Egg (embryo)
laying by gravid hermaphrodites is a complex neuroendocrine
behavior involving serotonin and acetylcholine released by VC
and HSN neurons acting on the vulval muscles [38]. The rate of
egg laying is dependent on many variables, including animal age,
population density, and food supply. To eliminate some of these
variables, individual young gravid hermaphrodites were picked
into single wells of a 96-well micro titer plate containing M9
buffer. Exogenous serotonin (12.9 mM) was added to stimulate
wild type egg laying to a rate (,8 eggs/hr/animal) that could be
quantified easily within a 60 minute assay and various mutant
animals were tested. We found that pag-3(gv560) mutants had a
significant increase (,34%) in egg-laying compared to wild type
controls (Figure 5A). In comparison, ida-1(ok409) single mutants
and ida-1(ok409);pag-3(gv560) double mutants had a ,33% and
,26% reduction, respectively, in egg laying compared to wild type
controls. As observed for protein level changes, the egg-laying
phenotype of gv560 was dependent on wild type IDA-1 activity. To
control for possible effects of the extra VC-like neurons present in
gv560 animals on egg-laying, we also tested laying rates in ced-
3(n717) mutants that also have extra VC-like neurons; ced-3
mutant rates of egg laying were comparable to wild type animals
(data not shown). These results suggested that increased neurose-
cretion from the HSNs, and/or the VCs, and not the presence of
extra VC-like neurons, likely underlies the enhanced egg-laying
phenotype of gv560 mutants in response to serotonin.
As a second test of neurosecretion, we used the acetylcholin-
esterase inhibitor aldicarb to assess acetylcholine (Ach) release and
presynaptic function [39,40]. Ach release is traditionally consid-
ered an assay of SV function, not DCVs. However, it has been
previously shown that disruption of DCV function impaired,
directly or indirectly, the release of Ach [18,35,41,42]. We used a
population growth rate assay in which we counted the number of
progeny from parental animals after 96 hr of growth on plates
containing various concentrations of aldicarb [18,39]. This assay
provides a more sensitive and quantitative measure of aldicarb
sensitivity compared to scoring paralysis alone. We found that pag-
3(gv560) mutants showed greater sensitivity to aldicarb than wild
type animals (Figure 5B), suggesting that these mutants release
Figure 4. Increased levels of vesicle proteins in the pag-3(gv650) mutant are dependent on wild type IDA-1 activity. (A) Complete loss
of IDA-1 activity due to the ida-1 null deletion allele ok409 results in a moderate, but significant, reduction in the levels of some vesicle-associated
proteins (SNT-1 and RAB-3, *P,0.05) as indicated quantitatively at left and by Western blot signal to the right. All values are given as a percentage of
wild type that is arbitrarily set to 100% as indicated by an open box. Error bars indicated variation of individual antibody level. (B) The level of the
vesicle cargo component serotonin was compared in HSN neurons by immunofluorescent staining in the indicated four strains. Images show close up
of HSN cell body of an adult animal orientated with anterior to the left and dorsal to the top. Exposure times were identical for all images. Scale bar
represents 20 mm for all images. (C) The SNT-1 levels were compared by Western blots (shown at top and quantified below) in four different mutant
backgrounds as indicated. Note that the increased SNT-1 in gv560 mutants (**, P,0.01) is reduced to wild type levels when the IDA-1 activity is
removed in the ida-1(ok409);pag-3(gv560) double mutants. (D) Quantitative analysis of the images show in panel C confirmed that the signal intensity
increases seen in the gv560 mutant background are reduced to wild type levels in the ida-1(ok409);pag-3(gv560) double mutants (**, P,0.01). Note
that the double mutant levels are not identical to ida-1(ok409), suggesting there may be a small, IDA-1-independent effect of the pag-3 mutation on
serotonin.
doi:10.1371/journal.pgen.1000447.g004
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mutant animals showed resistance to aldicarb as previously
reported [18] due to disruption of DCV function and decreased
neurosecretion. Again, the gv560 aldicarb phenotype was sup-
pressed in double mutant combination with ida-1(ok409). The
increased rates of egg-laying and increased sensitivity to aldicarb
observed for pag-3(gv560) are both consistent with enhanced
neurosecretion in these mutant animals.
We also investigated the role of pag-3 in dauer formation, an
alternative part of the life cycle in C. elegans that is regulated (in
part) by an insulin-like signaling pathway dependent on proper
neuroendocrine secretion. We compared dauer formation in wild
type, pag-3(gv650) and temperature-sensitive (ts) daf-28(sa191)
mutants, each reared at an elevated temperature of 25uC. The
wild type and pag-3 mutant animals showed no appreciable dauer
formation at this temperature (Figure 5C). In contrast, the daf-28
mutant harboring a ts allele of the insulin-like protein it encodes
resulted in 40% dauers due to reduced signaling through the
insulin-like signaling pathway at this temperature [43]. We found
that the daf-28(sa191);pag-3(gv650) double mutant resulted in a
,75% reduction in dauer formation at 25uC compared to daf-
28(sa191) alone (Figure 5C) demonstrating enhanced signaling
through the pathway. This result is consistent with our egg-laying
and aldicarb assays and together suggested that loss of PAG-3
activity results in enhanced neuroendocrine secretion affecting
many cell types.
Presynaptic DCV Numbers are Up-Regulated in pag-
3(gv560) and Down-Regulated in ida-1(ok409) Mutants
Previous cell culture work showed that DCV numbers are
increased 2,3-fold following over expression of mammalian IA-2
in mouse MIN6 cells, as assayed by vesicle counts from electron
micrographs [14]. We have demonstrated here that IDA-1/IA-2 is
up-regulated in pag-3 mutants, perhaps similarly resulting in
increased DCV numbers and increased neurosecretion. Although
technically challenging in C. elegans, we sought to determine by
electron microscopy if the overexpression of ida-1 observed in pag-
3(gv560) mutants was accompanied by increased numbers of
DCVs per neuron. Wild type and mutant animals were fixed,
sectioned and examined by electron microscopy (see Materials and
Methods). We focused on the ventral nerve cord region and
identified presynaptic regions by serial sections; individual neurons
in any section were not precisely identified. We found that the
average density of presynaptic region DCVs in pag-3(gv560) was
about twice the value of that in wild type controls (Figure 6A, B,
Table 1. mRNA Levels of Vesicle-related Genes Assayed by
RT-PCR.
C. elegans Mammalian
Relative Ratio
(gv560/N2) References
Encoding DCV membrane-associated proteins
arf-6 ARF6 1.0260.01 [77]
ida-1 IA-2 8.5560.03 [7]
rab-3 RAB3 0.9760.04 [34]
snt-1 Synaptotagmin 4.1360.63 [30]
Encoding DCV cargo
egl-3 PC2 1.1960.03 [78]
flp-1 FMRFamide 1 0.9860.05 [79]
ins-1 Insulin-like gene 1 3.0460.19 [80]
nlp-1 Neuropeptide-like 0.9260.06 [81]
Encoding SV membrane-associated proteins
snb-1 Synaptobrevin I 1.0160.08 [32]
snn-1 Synapsin 0.9060.11 [82]
sph-1 Synaptophysin 1.0360.06 [83]
unc-26 Synaptojanin 1.1160.19 [83]
Encoding non-vesicle proteins
act-1 Actin 1.1560.02 [84]
myo-1 Myosin 1.0860.03 [84]
tba-2 Tubulin, a1 1.0660.05 [85]
Total RNA was prepared from young adult N2 or pag-3(gv560) animals.
doi:10.1371/journal.pgen.1000447.t001
Figure 5. Neurosecretory phenotypes of pag-3(gv650) are
enhanced and are dependent on wild type IDA-1 activity. (A)
An egg-laying assay was used to monitor neurosecretory behavior in
wild type and mutant animals as described in the text. The average
number eggs laid in pag-3(gv560) mutant animals is much higher than
that in wild type animals (**, p,0.01), indicative of increased
neurosecretion in the pag-3 mutant. Both ida-1(ok409) single mutant
and ida-1(ok409);pag-3(gv560) double mutants laid less eggs than wild
type controls (*, p,0.05), demonstrating that ida-1 is epistatic to pag-3
for this phenotype. Data presented as the mean6SE (n=10). (B) pag-
3(gv560) mutants are hypersensitive to aldicarb. Shown are the aldicarb
dose-response curves for wild type (N2), pag-3(gv560), and ida-1(ok409)
single mutants and ida-1(ok409);pag-3(gv560) double mutants. In-
creased neurosecretion makes animals hypersensitive to aldicarb
(reduced survival), as is seen in the pag-3(gv560) mutant. The
hypersensitivity of pag-3(gv560) animals is suppressed to below wild
type levels in the ida-1(ok409);pag-3(gv560) double mutants. The one
hundred percent value represents the number of progeny produced
from a starting population of wild type L1 larvae over a 96 hr period in
the absence of aldicarb. Curves are representative of duplicate
experiments in three independent assays. (C) Wild type animals or
pag-3(gv560) mutants alone have no dauer phenotype at 25uC
compared to the daf-28(sa191) temperature sensitive allele that gives
rise to ,43% dauers at this temperature. The pag-3(gv560) mutation
suppresses the daf-28(sa191) mutant dauer phenotype from ,43% to
,9% (p,0.01).
doi:10.1371/journal.pgen.1000447.g005
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and found a 50% reduction compared to wild type (Figure 6C, E).
Of particular interest, we found that the pag-3(gv560);ida-1(ok409)
double mutants eliminated the increased DCV numbers observed
in the pag-3(gv560) single mutant (Figure 6D, E). Our results
demonstrate that presynaptic DCV numbers correlate with
neurosecretion-based phenotypes in the mutants studied. That is,
pag-3(gv560) mutants have increased numbers of presynaptic
DCVs in ventral cord neurons and display phenotypes of
enhanced egg-laying, enhanced aldicarb sensitivity, and enhanced
signaling through the insulin-like pathway. All of these enhanced
phenotypes are dependent on wild type IDA-1 activity.
Discussion
We have capitalized on the genetics of C. elegans to identify
factors that contribute to the regulation of dense core vesicles
(DCVs) and neuroendocrine secretion. Using a reporter gene to
mark DCVs in live animals, we carried out a genetic screen and
identified a mutation that results in both over and ectopic
expression of the reporter. The mutation, that behaves genetically
as a recessive null allele, results in an amino acid change (S223F) in
the fourth zinc finger of the transcription factor PAG-3/Gfi-1.
This mutation (gv560) results in increased gene expression and
levels of several DCV-associated proteins and increased numbers
of DCVs in presynaptic regions of ventral cord neurons. These
increases correlate with enhanced neurosecretory phenotypes in
pag-3 mutants and are dependent on wild type IDA-1, the lone C.
elegans PTP-like factor related to mammalian DCV membrane
proteins IA-2 and IA-2b. Although mutations in many other
genes, such as unc-4 and unc-37 [44,45], unc-86 [46,47] and the
EGL-46 mammalian homolog INSM1/IA-1 [48–50], have been
shown to decrease SV and DCV components and numbers in
various neurosecretory systems, this is the first report we are aware
of in which a mutation results in DCV component up-regulation.
The results of this and previous work suggest that DCV
homeostasis is regulated by both stimulatory and inhibitory
mechanisms that correlate with levels of IDA-1-related proteins.
Our genetic studies demonstrate that the up-regulation of DCV
protein components in pag-3 mutants is dependent on functional
IDA-1 activity. It is possible that this dependence is indirect, with
IDA-1 and PAG-3 acting in separate pathways of DCV regulation.
For example, the enhanced neurosecretory phenotypes of pag-
3(gv560) could be suppressed by loss of IDA-1 activity due simply
the averaged effects (one positive and one negative) of the two
individual mutant phenotypes, each acting in different regulatory
cascades. We do not favor this explanation for two reasons. First,
both ida-1 transcription and IDA-1 levels are elevated in pag-3
mutants. Second, where quantifiable, the genetic interactions
between ida-1 and pag-3 mutants we observe strongly suggest an
epistatic relationship. That is, the ida-1(ok409);pag-3(gv560) double
mutants more closely resemble ida-1(ok409) alone (with the
exception of gene expression) rather than a quantitative average
of ida-1(ok409) and pag-3(gv560) effects together. These results
Figure 6. Changes in the presynaptic region number of dense core vesicle in pag-3 and ida-1 mutants. Electron micrographs of
unidentified ventral cord neurons showing the characteristic presynaptic density (black arrows) from wild type animals (A), pag-3(gv560) mutants (B),
ida-1(ok409) mutants (C), and ida-1(ok409);pag-3(gv560) double mutants (D). Large dense core vesicle-like structures are indicated by white arrows in
all panels. The scale bar represents 100 nm for all images. (E) The average number of DCVs per presynaptic region was quantified relative to wild type
controls. The pag-3(gv560) mutants have an increased number of DCVs, whereas the ida-1(ok409) single mutants and ida-1(ok409);pag-3(gv560)
double mutants have significantly decreased numbers (**p,0.01, *p,0.05). Note also that the DCVs in pag-3(gv560) mutants (panel B) are
consistently smaller in size and often irregularly shaped. Error bars are one standard deviation.
doi:10.1371/journal.pgen.1000447.g006
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pathway to regulate DCV homeostasis.
A model consistent with our results places IDA-1 in an
important position in the modulation of DCV numbers and
secretion by directly influencing their biogenesis, stability and/or
utilization (Figure 7). Actions that increase IDA-1 (e.g. loss of
PAG-3) result in increased presynaptic DCV numbers and
increased neurosecretion whereas actions that decrease IDA-1
(e.g. loss of IDA-1 itself) result in decreased DCVs and secretion.
Loss of both PAG-3 and IDA-1 in double mutant animals results
in a DCV phenotype resembling loss of IDA-1. This demonstrates
that effects of increased transcription of some DCV component
genes, due to loss of PAG-3, are masked by the loss of the post-
transcriptional role of IDA-1 in influencing the biogenesis,
stability, or utilization of DCVs. The molecular mechanism
whereby IDA-1 influences DCV steady state levels is currently
unknown and represents an important area for future research.
Although IDA-1 activity is an important barometer of DCV
homeostasis, it is worth noting that it is not essential for DCV
formation and organism viability. Instead, its loss or hyper
production in C. elegans results in an approximately 2-fold swing,
down or up respectively, in DCV numbers. Thus, IDA-1 is part of
a larger and as yet undefined, multi-component regulatory system
that ensures DCV numbers and cargo reflect the neurosecretory
demands of the cell.
Our results are consistent with recent results from vertebrate
studies, providing an organismal context for understanding IDA-
1/IA-2 function in DCV regulation. Over expression of mouse IA-
2 in insulin-expressing MIN6 cells markedly increased induced
insulin secretion and the number of DCVs [14]. Studies by
Solimena and colleagues have provided evidence that after fusion
of the DCV with the plasma membrane during insulin secretion,
the cytosolic tail of IA-2 (containing the catalytically inactive PTP-
like domain) is cleaved by a calcium-induced and calpain-
Figure 7. Model of DCV stability by IDA-1. The center schematic shows the wild type scenario in which DCV numbers, cargo, and neurosecretion
are regulated by both transcriptional and post-transcriptional mechanisms. Gene X is one, or more, hypothetical components or regulators of DCV
biogenesis, utilization, or stability. The expression of Gene X is controlled by the balanced activities of both positive regulators (activator) and negative
regulators, represented here by PAG-3 binding to a canonical Gfi1 promoter sequence (AATCNNG). IDA-1, one candidate for being encoded by Gene
X, serves to regulate DCV numbers or turnover post-transcriptionally, thus affecting neurosecretory levels. The left panel shows the consequences of
loss of IDA-1 in null mutants; DCV biogenesis and/or turnover are altered, resulting in deceased presynaptic DCV numbers and decreased
neurosecretion. The right panel shows the effects of loss of the putative negative transcriptional regulator PAG-3. Gene X transcription increases with
resulting increases in IDA-1, DCV numbers, cargo and neurosecretion, an effect that can be mimicked by increasing IA-2 levels in mammalian cell
culture [14].
doi:10.1371/journal.pgen.1000447.g007
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cleavage event initiates a retrograde signal in which the IA-2
cytosolic domain enters the nucleus to complex with the
transcription factors STAT3 and STAT5, thereby blocking their
inactivation by de-phosphorylation [15,52]. In this model, IA-2 is
a critical element that links DCV exocytosis to feedback regulation
of transcription such that genes encoding IA-2 and other DCV
components and cargo are up-regulated upon induced insulin
secretion. We find in C. elegans that all up-regulated changes in
DCV numbers and secretory behaviors due to pag-3 mutations are
ameliorated by loss of IDA-1/IA-2. However, loss of IDA-1 has no
effect on the steady state mRNA levels of any vesicle-related genes
we assayed (listed in Table 1), nor do we ever detect our IDA-
1::GFP translation fusion protein in the nucleus. Thus, functional
IDA-1 appears to be necessary post-transcriptionally for the
coordinated regulation of DCV biogenesis and utilization,
although we have no evidence that reveals the molecular
mechanisms by which this occurs. We were unable to link these
effects genetically to the single C. elegans STAT encoding gene sta-
1, suggesting that any feedback mechanisms that function in C.
elegans are not entirely dependent on STAT activity. Similarly,
both of the pancreatic b-cell-specific STAT3 and STAT5
knockout mice showed normal insulin content and islet mass
[53,54], suggesting that STAT3 and STAT5 are functionally
redundant or are not critical elements for insulin-containing DCV
regulation. It is also possible that other transcription factors act
redundantly with the STATs, thereby masking the effects of STAT
loss of function in this process in both C. elegans and mice.
Regardless of the role of STAT activity in DCV regulation, our
results reveal an additional, post-transcriptional mechanism
whereby IDA-1 influences DCV homeostasis.
Our work reveals a novel transcriptional link between IDA-1/
IA-2 and DCV regulation that is mediated by PAG-3. PAG-3 is a
five C2H2-type zinc finger transcription factor and it is orthologous
to vertebrate Gfi-1 (growth factor independence-1) and Drosophila
Senseless [28,55,56]. In the C. elegans nervous system, PAG-3
appears to function primarily as a transcriptional repressor [28], a
theme common to the functions described to date for its vertebrate
and Drosophila orthologs [23,57]. Interestingly, we find a similar
mis-regulation of our IDA-1::GFP reporter gene in unc-3 mutant
animals (unpublished). UNC-3 was recently identified as PAG-3
interacting protein and is an ortholog of the Olf-1/Early B cell
factor family of transcription factors involved in neuronal cell
development [58]. It is possible that PAG-3 and UNC-3 act
together as part of a common transcriptional complex that can
influence, directly or indirectly, the expression of genes whose
products are necessary for DCV homeostasis. However, the
relationship between the activities of these two factors appears to
be complex. UNC-3 has not been reported in the VC4 and VC5
neurons [58] that show mis-regulation of IDA-1::GFP in the pag-3
mutant background. In addition, our rescue experiments demon-
strate that PAG-3 acts cell autonomously in VC4 and VC5 with
respect to IDA-1 up-regulation. Finally, unc-3 and pag-3 mutants
have different cell lineage transformations underlying their extra
VC and VC-like neuron phenotypes [58]. Taken together, these
results suggest that UNC-3 and PAG-3 may act at multiple times
in the cell lineage giving rise to these cells, perhaps both together
and independently. Characterizing the neurosecretory phenotypes
of unc-3 mutants and exploring the molecular mechanisms that
might link UNC-3 and PAG-3 are challenges for future studies.
Given the dramatic up-regulation of ida-1 gene expression and
other DCV-associated gene products in pag-3 mutants, it is
tempting to speculate that PAG-3 directly represses ida-1 and
other DCV component gene expression. We have used the known
binding site of PAG-3 in vitro, as well as its related mammalian
factors, to search bioinformatically for promoters containing
matching sequences. Although several of the DCV genes we
searched, including ida-1, do have sequences within their
promoters that resemble the consensus Gfi-1 binding site [59],
our attempts (and that of others) to demonstrate direct PAG-3
binding in vitro have not been successful. Therefore, the question of
whether the effects of pag-3 mutations on DCV component gene
expression are direct or indirect remains unanswered.
Identification of PAG-3 as a factor involved in DCV regulation
may have clinical relevance. Recent studies show that mammalian
Gfi-1/PAG-3 is involved in the regulation of neuroendocrine cell
development and controls neuroendocrine cancer growth [60,61]
(also see review by [62]). Gfi-1 co-expression with neuroendocrine
markers, including the DCV-related protein chromogranin A and
calcitonin peptide, in small cell lung carcinoma (SCLC) strongly
suggests its involvement in the maintenance of the neoplastic
phenotype of neuroendocrine lung tumors [60]. We have shown
previously that IA-2 is strongly expressed in many small cell lung
carcinoma (SCLC) cells with a neuroendocrine phenotype, but not
in non-neuroendocrine carcinomas [63]. In fact, IA-2 is expressed
in many other, if not all, human neuroendocrine cancer cells
examined such as insulinoma [64] and serotonin-secreting tumors
of the midgut [65]. Our current results suggest that deregulation of
Gfi-1/PAG-3 in neuroendocrine neoplastic disease may severely
alter IA-2-related homeostatic control. This dysregulation may
contribute directly to the tumor hypersecretion phenotypes that
are caused by more than twenty of the different neuropeptides and
hormones abnormally released from DCVs such as gastrin-
releasing peptide, chromogranin A, atrial natriuretic peptide
(ANP), and growth hormone-releasing hormone [66–69]. Further
studies are required to look for mutations in neuroendocrine
pathway genes and to examine directly the role of Gfi-1/PAG-3
and IA-2 in SCLC and related neuroendocrine cancers.
Our current study adds to a growing body of evidence linking
IA-2-related protein levels to neuroendocrine secretion and
highlights the usefulness of model organisms in dissecting basic
biological mechanisms. For human diseases that might benefit
from increased neurosecretion, such as diabetes mellitus, targeted
knockdown of Gfi-1 function represents a potential therapeutic
target. Although there is substantial evidence linking IA-2 protein
levels to DCV numbers and secretion, the molecular mechanisms
underlying DCV homeostasis and its link to transcriptional control
remain unclear. The identification of PAG-3/Gfi-1 as a
component of this regulatory system provides another clue for
increasing our understanding of these molecular mechanisms.
Materials and Methods
Strains
C. elegans were grown at 20uC on NGM plates seeded with
OP50 bacteria [70] unless otherwise noted. Strains and alleles used
were as follows: wild type (N2), CB4856, ida-1(ok409),
KM246{gvIs246[Pida-1IA-2::gfp]}, pag-3(ls20), pag-3(n3098), pag-
3(gv560);gvEx[pag-3(+)], ced-3(n717), unc-3(e151), unc-7(e5), daf-
28(sa191), unc-31(e928), unc-64(e246) and sta-1(ok587). A N2 strain
harboring Plin-11::GFP was kindly provided by Michael R. Koelle.
Double mutants were confirmed by phenotype, molecular
genotyping of specific alleles, or both.
Screen for Mutations Leading To Increased IDA-1::GFP
Expression
Transgenic L4 larvae of the strain harboring the IDA-1::GFP
translational fusion reporter (KM246)[18] were treated with ethyl
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worms were placed on seeded 10-cm NGM agar plates and
allowed to lay eggs overnight. 2200 individual F1 mutagenized
animals were separated onto 550 plates and visually screened three
days later as young adults for alterations in IDA-1::GFP in VC and
ALA neurons, using a dissecting fluorescence microscopy. Among
the mutants examined, we recovered a single penetrant mutation
that showed increased IDA-1::GFP expression in neuronal cells.
This recessive mutation, gv560, was out crossed four times and
mapped to LGX.
Total RNA Preparation and cDNA Analysis
Worms were harvested, washed twice with M9 buffer, and
frozen in liquid nitrogen. For RNA preparation, worms were
thawed at 65uC for 10 min, and RNA was isolated using the
TRIZOL LS Reagent (Invitrogen, Carlsbad, CA). Isolated total
RNA was subjected to DNAse treatment and further purified
using RNAeasy (Qiagen, Valencia, CA). cDNA was prepared from
5 mg of total RNA in a 100 ml reaction using the SuperScript First-
Strand Synthesis System (Invitrogen). The cDNA was used in
quantitative real-time PCR (RT-qPCR) using standard conditions.
Primer pairs and probes (sequences available upon request) were
diluted into 96-well plates at a concentration of 3 mM. Real-time
amplification of the cDNA was performed using the TaqMan
Universal Master Mix (Applied Biosystems, Foster City, CA). All
RT-PCR reactions were carried out and analyzed on an ABI-
Prism 9700TH Sequence Detection System (Applied Biosystems),
according to the manufacturer’s directions. Data were collected
using RNA from three independent C. elegans populations. To
determine the relationship between mRNA abundance and PCR
cycle number, all primer sets were calibrated using serial dilutions
of cDNA preparations. Relative abundance is reported as the
mRNA abundance of each experimental gene relative to the
mRNA abundance of several control genes.
Western Blots and Immunostaining
Western blots were performed using Amersham ECL Plus
TM
Western Blotting Detection Reagents (GE Healthcare Bio-
Sciences Corp, Piscataway, NJ). Immunostaining was performed
using a modified protocol [18]. Antisera against an IDA-1 peptide
corresponding to amino acid residues 47–61 (CYSSESG-
SPEPTVLD) was produced in rabbits and purified with
Immobilized Protein G Agarose (Pierce Biotechnology, Rockford,
IL). Antisera against synaptotagmin (antibody 1095, kindly
provided by M. Nonet, Washington University School of
Medicine, St. Louis, MO), IDA-1/IA-2 (J. Hutton, University of
Colorado at Denver, CO), UNC-31 (K. Miller, Oklahoma
Medical Research Foundation, Oklahoma City, OK), and RAB-
3 (K. Iwasaki, National Institute of Bioscience and Human
Technology, Ibaraki, Japan) were used as described [71]. Antisera
against serotonin were from H. Steinbusch (Maastricht University,
Maastricht, Netherlands) and detected using the method of Loer
(http://home.sandiego.edu/,cloer/loerlab/anti5htshort.html),
anti-synaptobrevin (SNB-1) from Developmental Studies Hybrid-
oma Bank (University of Iowa, IA), and anti-GFP antibodies from
Clontech (Palo Alto, CA). Antibodies were detected using
rhodamine- or FITC-conjugated goat anti-rabbit or anti-mouse
secondary antibodies (Jackson ImmunoResearch, West Grove,
PA).
Analysis of IDA-1::GFP Intensity
Animals were grown at 20uC and different life stages were
analyzed from a growing population. For image acquisition,
animals were incubated with 10 mM NaN3 in M9 buffer for 1 h
and mounted on agar pads. Stacks of confocal images with 0.3 to
0.4 mm vertical pitch were recorded with identical exposure times
using a Leica TCS SP2 microscope. Maximum intensity
projections of all images from a given animal were generated
using the NIH ImageJ software package (http://rsbweb.nih.gov/
ij/download.html).
Egg-Laying Assays
Individual young hermaphrodites were placed in 96 wells of a
microtiter plate containing 12.9 mM serotonin creatinine sulfate
(Sigma) in 100 ml of M9 buffer [72]. After 60 min incubation at
room temperature, the eggs laid by each animal were counted. All
assays were performed in triplicate (n=10).
Aldicarb Assays
Chronic effects of aldicarb on mutants were quantified in a
growth assay as previously described [18,39,73]. Single L1 larva
were placed on individual culture plates containing 0, 10, 25, 50,
75, 100, 200, 300, or 400 mM aldicarb and grown at room
temperature (22uC) for 96 hr. Growth was then stopped by putting
the plates at 4uC. For each aldicarb concentration, the number of
progeny was counted as a percentage of the total number of
progeny produced on the no-drug control. Triplicate assays were
performed and an N2 control set was included with each set of
strains to allow for comparisons between different sets of assays.
Dauer Formation
Adults were allowed to lay eggs on bacterially seeded plates for
3 hr at room temperature and progeny were scored after 48 hr at
25uC as indicated in results [18,74]. Dauers were distinguished by
the distinctive body shape, darkly pigmented intestine, and a
constricted pharynx. Each set of assays included all of the relevant
strains and the actual ambient incubator temperature surrounding
the plates was monitored with a digital thermometer (Barnant Co.,
Barrington, IL).
Chromosomal Mapping and Rescue
Genetic mapping was carried out using single nucleotide
polymorphisms (SNPs) [75]. The gv560 mutant allele was crossed
into the CB4856 wild type strain [76]. F2 Unc progeny with extra
VC-like neurons (P9–P12) were scored for the presence of CB4856
SNP markers. Thirteen SNP markers were selected between the
interpolated genetic map position 2.86,23.92 on the X
chromosome; pkP6114 (C05C9), pkP6060 (C35C5), pkP6130
(B0198), pkP6125 (C23H4), pkP6131 (K02A4), pkP6115 (C05E7),
pkP6161 (F11C1), pkP6132 (F46G10), pkP6133 (C49F8), pkP6164
(R03E1), pkP6116 (F33C8), pkP6087 (C33A11), pkP6093
(F01G12). Detailed location and primer sequence of each SNP
are provided at the Genome Sequencing Center (http://genome.
wustl.edu/genome/celegans/celegans_snp.cgi). The gv560 allele
was mapped between SNP marker pkP6116 on cosmid F33C8 and
pkP6093 on cosmid F01G12. To confirm the gene location of
gv560, small PCR fragments (1 kb in size) covering the ,2-kb
promoter region, entire coding region, and intron-exon junction
regions of pag-3 were generated for sequencing (ABI 373 DNA
sequencer). Primer sequences are available upon request. Further
confirmation of the pag-3(gv560) mutation was provided by
rescuing the mutant phenotypes with a 6.5-kb genomic fragment
covering the entire coding region of pag-3 that was amplified by
long-PCR (TaKaRa LA Taq DNA Polymerase, Takara Bio USA
Corporate, Madison, WI). Animals were injected with the purified
PCR products at 1–10 ng/ml together with the co-injection
marker pRF4 (rol-6(su1006)) at 100 ng/ml and analyzed for rescue
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the effect of pag-3 mutants on IDA-1::GFP expression is a cell
autonomous, the full-length cDNA of pag-3 was specifically
expressed in a limited number of neurons (including VC4 and
VC5) driven by the 3-kb promoter of cat-1 to generate Pcat-1PAG-3
in the PCRII-TOPO vector that was confirmed by sequencing.
Ultrastructural Analysis
Ten N2, pag-3(gv560), pag-3(gv560);ida-1(ok409), and ida-
1(ok409) young adult hermaphrodites were subjected to high-
pressure freezing. Animals were placed in a 100-mm depth
specimen chamber (part no. LZ 02316VN, Technotrade Interna-
tional), frozen rapidly at 2176uC under high pressure (pressure
.2,100 bar) in a Bal-Tec HPM010 apparatus. Frozen animals
were subjected to chemical fixation and dehydration in a Reichart
AFS apparatus (Leica): incubation with 0.1% tannic acid and
0.5% glutaraldehyde in anhydrous acetone for 72 h at 290uC
followed by several washes in acetone over 6 h. Samples were
moved to 2% osmium tetradioxide in anhydrous acetone for 4 h at
290uC before raising the temperature to 220uCa t5 uC/h.
Samples were then incubated for 16 h at 225uC before raising the
temperature to 4uC over 3 h. Samples were then washed in
anhydrous acetone for 3 times, each for 15 min and embedded in
Epon-Araldite during a 48-h period at 60uC. Blocks were
subsequently sectioned and analyzed. Serial sections (80 nm) were
counterstained and imaged on CM 120 transmission electron
microscope at 120 kV with a Gatan digital camera. A synapse was
defined in serial sections that contained the same presynaptic
specialization in at least three consecutive sections. Fifteen total
ventral cord synapses from two WT animals and seven total
ventral cord synapses from two pag-3(gv560) animals and eight
total ventral cord synapses from two pag-3(gv560);ida-1(ok409) or
two ida-1(ok409) animals were analyzed.
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